Anavex Life Sciences annual depreciation and amortization
2010
2011
2012
2013
2014
2015
2016
Anavex Life Sciences Depreciation & Amortization Growth & History (AVXL)
Anavex Life Sciences's depreciation and amortization was $1,252 for fiscal 2016.
View full Anavex Life Sciences company overviewAnavex Life Sciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2016 | 2016-09-30 | $1,252 | $257 | +25.83% |
| 2015 | 2015-09-30 | $995 | $227 | +29.56% |
| 2014 | 2014-09-30 | $768 | $192 | +33.33% |
| 2013 | 2013-09-30 | $576 | −$1,282 | −69.00% |
| 2012 | 2012-09-30 | $1,858 | $201 | +12.13% |
| 2011 | 2011-09-30 | $1,657 | $747 | +82.09% |
| 2010 | 2010-09-30 | $910 | — | — |
Anavex Life Sciences quarterly depreciation and amortization
Q3.10
Q1.11
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q1.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2016 | 2016-06-30 | $249 | $1 | +0.40% |
| Q2 2016 | 2016-03-31 | $248 | −$1 | −0.40% |
| Q1 2016 | 2015-12-31 | $249 | $0 | 0.00% |
| Q3 2015 | 2015-06-30 | $248 | $56 | +29.17% |
| Q2 2015 | 2015-03-31 | $249 | $57 | +29.69% |
| Q1 2015 | 2014-12-31 | $249 | $57 | +29.69% |
| Q3 2014 | 2014-06-30 | $192 | $192 | — |
| Q2 2014 | 2014-03-31 | $192 | $81 | +72.97% |
| Q1 2014 | 2013-12-31 | $192 | −$273 | −58.71% |
| Q3 2013 | 2013-06-30 | $0 | −$465 | — |
| Q2 2013 | 2013-03-31 | $111 | −$354 | −76.13% |
| Q1 2013 | 2012-12-31 | $465 | $1 | +0.22% |
| Q3 2012 | 2012-06-30 | $465 | $88 | +23.34% |
| Q2 2012 | 2012-03-31 | $465 | $58 | +14.25% |
| Q1 2012 | 2011-12-31 | $464 | −$27 | −5.50% |
| Q3 2011 | 2011-06-30 | $377 | $187 | +98.42% |
| Q2 2011 | 2011-03-31 | $407 | — | — |
| Q1 2011 | 2010-12-31 | $491 | — | — |
| Q3 2010 | 2010-06-30 | $190 | — | — |
Anavex Life Sciences depreciation and amortization trends
Over the last five fiscal years, Anavex Life Sciences's depreciation and amortization decreased from $1,657 to $1,252, a change of −$405. The latest reported quarter, Q3 2016, shows $249.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Anavex Life Sciences source filings ↗